E. Clay, B. Falissard, N. Moore, and M. Toumi, Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries

J. Woolcott, K. Richardson, M. Wiens, B. Patel, J. Marin et al., Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons, Archives of Internal Medicine, vol.169, issue.21, pp.1952-1960, 2009.
DOI : 10.1001/archinternmed.2009.357

D. Hogan, C. Maxwell, T. Fung, and E. Ebly, Canadian Study of Health and Aging: Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging, Can J Clin Pharmacol, vol.10, pp.72-77, 2003.

G. Belleville, Mortality Hazard Associated with Anxiolytic and Hypnotic Drug Use in the National Population Health Survey, The Canadian Journal of Psychiatry, vol.27, issue.3, pp.558-567, 2010.
DOI : 10.1177/070674371005500904

F. Charlson, L. Degenhardt, J. Mclaren, W. Hall, and M. Lynskey, A systematic review of research examining benzodiazepine-related mortality, Pharmacoepidemiology and Drug Safety, vol.156, issue.3, pp.93-103, 2009.
DOI : 10.1002/pds.1694

S. Billiotidegage, B. Bégaud, F. Bazin, H. Verdoux, J. Dartigues et al., Benzodiazepine use and risk of dementia: prospective population based study, BMJ, vol.2012, issue.345, p.6231

A. European-medicines, Summary of product characteristics for benzodiazepines as anxiolytics or hypnotics, 2009.

R. Française, Arrêté du 22 septembre 2011 portant approbation de la convention nationale des médecins généralistes et spécialistes

. Hauteautoritédesanté, Modalités d'arrêt des benzodiazépines et médicaments apparentés chez le patient âgé. [http://www.has-sante.fr/portail/ jcms/c_601509/modalites-d-arret-des-benzodiazepines-et-medicaments- apparentes-chez-le-patient-age?xtmc=benzodiazépines&xtcr=4

K. Mugunthan, T. Mcguire, and P. Glasziou, Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis, British Journal of General Practice, vol.61, issue.590, pp.573-578, 2011.
DOI : 10.3399/bjgp11X593857

C. Denis, M. Fatséas, E. Lavie, and M. Auriacombe, Pharmacological interventions for benzodiazepine mono-dependence management in outpatients settings, Cochrane Database Syst Rev, 2006.

G. Liu and D. Christensen, The Continuing Challenge of Inappropriate Prescribing in the Elderly: An Update of the Evidence, Journal of the American Pharmaceutical Association (1996), vol.42, issue.6, pp.847-857, 2002.
DOI : 10.1331/108658002762063682

P. Wangs, R. Bohn, R. Glynn, H. Mogun, and J. Avorn, Hazardous Benzodiazepine Regimens in the Elderly: Effects of Half-Life, Dosage, and Duration on Risk of Hip Fracture, American Journal of Psychiatry, vol.158, issue.6, pp.892-898, 2001.
DOI : 10.1176/appi.ajp.158.6.892

B. Bongue, M. Laroche, S. Gutton, A. Colvez, R. Guéguen et al., Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system, European Journal of Clinical Pharmacology, vol.363, issue.3, pp.1291-1299, 2011.
DOI : 10.1007/s00228-011-1077-5

M. Jardin, A. Bocquier, S. Cortaredona, S. Nauleau, C. Millon et al., Verger P: [Potentially inappropriate prescriptions for the elderly: a study of health insurance reimbursements in Southeastern France]. Rev Epidemiol Sante Publique, pp.121-130, 2012.

J. Parr, D. Kavanagh, L. Cahill, and G. Mitchell, Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis, Addiction, vol.62, issue.1, pp.13-24, 2008.
DOI : 10.1111/j.1360-0443.2008.02364.x

N. Lechevallier-michel, M. Gautier-bertrand, A. Alpérovitch, C. Berr, J. Belmin et al., Fourrier-Réglat A, 3C Study Group: Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study

F. Public and H. Code, Article R. 1121-2

A. Scott, P. Sivey, A. Ouakrim, D. Willenberg, L. Naccarella et al., The effect of financial incentives on the quality of health care provided by primary care physicians, Cochrane Database Syst Rev, vol.9, p.8451, 2011.

G. Flodgren, M. Eccles, S. Shepperd, A. Scott, E. Parmelli et al., An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes, Cochrane Database Syst Rev, vol.49, issue.443, p.9255, 2011.
DOI : 10.1002/14651858.CD009255

C. Rat, E. Werner, J. Pivette, R. Senand, and J. Nguyen, Hypnotic prescription without face to face contact: A report from French family medicine, European Journal of General Practice, vol.6, issue.3, pp.158-161, 2013.
DOI : 10.3109/13814788.2013.777423

S. Leikola, M. Dimitrow, A. Lyles, K. Pitkälä, and M. Airaksinen, Potentially Inappropriate Medication Use Among Finnish Non-Institutionalized People Aged ???65 Years, Drugs & Aging, vol.35, issue.2, pp.227-236, 2011.
DOI : 10.2165/11586890-000000000-00000

K. Johnell, J. Fastbom, M. Rosén, and A. Leimanis, Inappropriate Drug Use in the Elderly: a Nationwide Register-Based Study, Annals of Pharmacotherapy, vol.62, issue.7-8, pp.1243-1248, 2007.
DOI : 10.1345/aph.1K154

L. Van-dijk, Reimbursement restriction and moderate decrease in benzodiazepine use in general practice, Ann Fam Med, vol.10, pp.42-49, 2012.

B. Kollen, W. Van-der-veen, F. Groenhof, G. Donker, and K. Van-der-meer, Discontinuation of reimbursement of benzodiazepines in the Netherlands: does it make a difference?, BMC Family Practice, vol.266, issue.17, p.111, 2012.
DOI : 10.1001/jama.1991.03470170080028

J. Cook, R. Marshall, C. Masci, and J. Coyne, Physicians??? Perspectives on Prescribing Benzodiazepines for Older Adults: A Qualitative Study, Journal of General Internal Medicine, vol.1, issue.4, pp.303-307, 2007.
DOI : 10.1007/s11606-006-0021-3

C. Otte, Cognitive behavioral therapy in anxiety disorders: current state of the evidence, Dialogues Clin Neurosci, vol.13, pp.413-421, 2011.

S. Anthierens, I. Pasteels, H. Habraken, P. Steinberg, T. Declercq et al., Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia, Can Fam Physician, vol.56, pp.398-406, 2010.

M. Karanikolos, P. Mladovsky, J. Cylus, S. Thomson, S. Basu et al., Financial crisis, austerity, and health in Europe, The Lancet, vol.381, issue.9874, pp.1323-1331, 2013.
DOI : 10.1016/S0140-6736(13)60102-6

M. Gili, M. Roca, S. Basu, M. Mckee, and D. Stuckler, The mental health risks of economic crisis in Spain: evidence from primary care centres, 2006 and 2010, The European Journal of Public Health, vol.23, issue.1, pp.103-108, 2006.
DOI : 10.1093/eurpub/cks035

D. Stuckler, S. Basu, M. Suhrcke, A. Coutts, and M. Mckee, Effects of the 2008 recession on health: a first look at European data, The Lancet, vol.378, issue.9786, pp.124-125, 2011.
DOI : 10.1016/S0140-6736(11)61079-9

B. Barr, D. Taylor-robinson, A. Scott-samuel, M. Mckee, and D. Stuckler, Suicides associated with the 2008-10 economic recession in England: time trend analysis, BMJ, vol.345, issue.aug13 2, p.5142
DOI : 10.1136/bmj.e5142

M. Economou, M. Madianos, C. Theleritis, L. Peppou, and C. Stefanis, Increased suicidality amid economic crisis in Greece, The Lancet, vol.378, issue.9801, p.1459, 2011.
DOI : 10.1016/S0140-6736(11)61638-3

C. Frels, P. Williams, S. Narayanan, and S. Gariballa, Iatrogenic causes of falls in hospitalised elderly patients: a case-control study, Postgraduate Medical Journal, vol.78, issue.922, pp.487-489, 2002.
DOI : 10.1136/pmj.78.922.487

C. Neutel, J. Hirdes, C. Maxwell, and S. Patten, New Evidence on Benzodiazepine Use and Falls: The Time Factor, Age and Ageing, vol.25, issue.4, pp.273-278, 1996.
DOI : 10.1093/ageing/25.4.273

A. Passaro, S. Volpato, F. Romagnoni, N. Manzoli, G. Zuliani et al., Benzodiazepines with different half-life and falling in a hospitalized population, Journal of Clinical Epidemiology, vol.53, issue.12, pp.1222-1229, 2000.
DOI : 10.1016/S0895-4356(00)00254-7

R. Leipzig, R. Cumming, and M. Tinetti, Drugs and Falls in Older People: A Systematic Review and Meta-analysis: I. Psychotropic Drugs, Journal of the American Geriatrics Society, vol.351, issue.suppl, pp.30-39, 1999.
DOI : 10.1111/j.1532-5415.1999.tb01898.x

S. Uzun, O. Kozumplik, M. Jakovljevi?, and B. Sedi?, Side effects of treatment with benzodiazepines, Psychiatr Danub, vol.22, pp.90-93, 2010.

M. Laroche, J. Charmes, and M. L. , Potentially inappropriate medications in the elderly: a French consensus panel list, European Journal of Clinical Pharmacology, vol.23, issue.8, pp.725-731, 2007.
DOI : 10.1007/s00228-007-0324-2

D. Greenblatt, R. Shader, M. Divoll, and J. Harmatz, Benzodiazepines: a summary of pharmacokinetic properties., British Journal of Clinical Pharmacology, vol.9, issue.Suppl. 2, pp.11-16, 1981.
DOI : 10.1111/j.1365-2125.1981.tb01833.x

P. Landry, M. Gervais, O. Connor, and K. , Mise ?? jour sur les consid??rations pharmacocin??tiques, pharmacodynamiques et les interactions m??dicamenteuses dans le choix d???une benzodiaz??pine, Annales M??dico-psychologiques, revue psychiatrique, vol.166, issue.7, pp.585-594, 2008.
DOI : 10.1016/j.amp.2008.06.008

E. Hoge, A. Ivkovic, and G. Fricchione, Generalized anxiety disorder: diagnosis and treatment, BMJ, vol.345, issue.nov27 2, p.7500
DOI : 10.1136/bmj.e7500
URL : http://www.bmj.com/cgi/content/short/345/nov27_2/e7500